Sonnet BioTherapeutics
(NASDAQ) SONN
Sonnet BioTherapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.00M
Net Income (TTM)
$16.11M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
SONN News
SONN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sonnet BioTherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
9
CEO
Raghu Rao, MBA
Website
www.sonnetbio.comHeadquarters
Princeton, NJ 08540, US
SONN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
-16%
Net Income Margin
-16%
Return on Equity
-5%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$15.84M
EBITDA
$15.84M
Operating Cash Flow
$12.83M
Capital Expenditure
$0.00
Free Cash Flow
$12.83M
Cash & ST Invst.
$5.12M
Total Debt
$46.57K
Sonnet BioTherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$930.33K
+4405.9%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
13
N/A
Net Income
$5.69M
-81.7%
EBITDA
$5.06M
-60.4%
Quarterly Fundamentals
Net Cash
$5.07M
+27189.6%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$46.57K
-44.7%
Return on Assets
-1.08%
N/A
Return on Invested Capital
-1.47%
N/A
Free Cash Flow
$5.69M
-79.4%
Operating Cash Flow
$5.69M
-79.4%